Illumina, Inc. (NASDAQ:ILMN) Q4 2022 Earnings Call Transcript
Operator: Good day, ladies and gentlemen, and welcome to the Fourth Quarter 2022 Illumina Earnings Conference Call. .
Posts Tagged ‘NASDAQ:ILMN’
Top 25 Smartest Companies To Buy According To Hedge Funds
In this piece, we will take a look at the top 25 smartest companies to buy according to hedge funds.
Analysts Are Cutting Price Targets of These 10 Stocks
In this article, we will discuss the 10 stocks whose price targets were recently trimmed by analysts.
Should You Hold Illumina (ILMN)?
Ensemble Capital Management, an investment management company, released its 2022 annual investor letter. A copy of the same can be downloaded here.
12 Blue Chip Stocks to Buy That Are Down Over 30% YTD
In this article, we take a look at 12 blue chip stocks to buy that are down over 30% YTD.
5 Best Genomics Stocks To Buy Now
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
5 Best Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best biotech stocks to buy according to hedge funds.
Alphabet Inc (GOOGL) Investment Portfolio: Top 15 Companies
In this article, we discuss the top 15 companies in Alphabet Inc (GOOGL)’s investment portfolio.
5 Biggest Genomics Companies In The World
In this article, we will discuss the 5 Biggest Genomics Companies In The World.
Do You Think Illumina (ILMN) is Undervalued?
Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2022 investor letter. A copy of the same can be downloaded here.
10 Best Pharmaceutical Stocks to Buy According to Steven Boyd’s Armistice Capital
In this article, we will take a look at some of the notable pharma stocks to buy according to Steven Boyd's Armistice Capital.
Analysts are Upgrading These 10 Stocks
In this article, we will take a look at the 10 stocks recently upgraded by analysts.
What’s Going On With Illumina (ILMN)?
Harding Loevner, an asset management company, released its “Global Equity” second quarter 2022 investor letter. A copy of the same can be downloaded here.
12 Best Medical Technology Stocks to Buy
In this article, we discuss 12 best medical technology stocks to buy.
10 Blue Chip Stocks to Buy Now According to Billionaire George Soros
In this article, we will take a look at the 10 Blue Chip Stocks to Buy Now According to Billionaire George Soros.
Is Illumina (ILMN) a Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Fifth Avenue Growth Fund” second quarter 2022 investor letter – a copy of which can be downloaded here.
5 Best Medical Device Stocks To Buy Now
In this piece we will take a look at the five best medical device stocks to buy now.
Top 10 Stocks to Watch Today
In this article, we will take a look at the top 10 stocks to watch today.
Baron Funds: “We Expect Illumina(ILMN) to Continue to Innovate & Introduce New Products”
Baron Funds, an asset management firm, published its “Baron Health Care Fund” second quarter 2022 investor letter – a copy of which can be downloaded here.
Illumina (ILMN) Is Radically Oversold
Ensemble Capital recently published its 2022 Q2 investor letter, a copy of which can be downloaded here.
Is Illumina (ILMN) a Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Opportunity Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
10 Stocks to Buy According to GuardCap Asset Management
In this article, we discuss 10 stocks to buy according to GuardCap Asset Management.
11 Earnings Reports Catching Investors’ Attention
In this article, we will take a look at the 11 earnings reports catching investors' attention.
Here’s Why You Must Remain Confident in Your Illumina (ILMN) Stake
Ensemble Capital, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be seen here.
Billionaire Andreas Halvorsen Is Selling These 10 Stocks
In this article, we discuss 10 stocks that billionaire Andreas Halvorsen is selling.
Here’s Why You Must Consider Buying Illumina (ILMN) Shares
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Did Hedge Funds Catch A Break With Illumina, Inc. (ILMN)?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Should You Now Consider Selling Your Illumina (ILMN) Shares?
Ensemble Capital, an investment management firm, published its fourth-quarter 2021 investor letter – a copy of which can be downloaded here.
10 Healthcare Stocks to Buy According to Billionaire DE Shaw
In this article, we discuss the 10 healthcare stocks to buy according to billionaire DE Shaw based on Q3 holdings of his fund.
10 Biotech Stocks To Buy According To Chinese Billionaire Lei Zhang
In this article, we discuss 10 biotech stocks to buy according to Chinese billionaire Lei Zhang.
5 Best Genomics Stocks to Buy Now
In this article, we will discuss the 5 best genomics stocks to buy now.
Was The Smart Money Right About Illumina, Inc. (ILMN)?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
10 Best Cancer Stocks To Buy Now
In this article, we discuss the 10 best cancer stocks to buy now.
Here’s Why Polen Capital Remains Positive in Illumina (ILMN)
Polen Capital, an investment management firm, published its “Polen Focus Growth” third quarter 2021 investor letter – a copy of which can be downloaded here.
5 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 5 best genomic stocks to buy now.
Here’s Why Illumina (ILMN) Landed in Ensemble Capital’s Detractor List
Ensemble Capital, an investment management firm, published its third-quarter 2021 investor letter – a copy of which can be downloaded here.
RiverPark Funds: “Illumina (ILMN) has Two Large Growth Opportunities Ahead”
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
Is Illumina (ILMN) an Interesting Stock to Buy?
DEVON Equity Management, an investment management firm, published its “Global Opportunities Fund” second quarter 2021 investor letter – a copy of which can be downloaded...
Is Illumina (ILMN) A Smart Long-Term Buy?
Ensemble Capital, an investment management firm, published its “Ensemble Fund” second quarter 2021 investor letter – a copy of which can be seen here. A quarterly portfolio...
5 Stocks Cathie Wood Is Selling
In this article, we discuss the 5 stocks Cathie Wood is selling.
Hedge Funds Are Buying Illumina, Inc. (ILMN)
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Is It Too Late to Buy Illumina (ILMN) Stock?
Bonsai Partners recently released its Q1 2021 Investor Letter, a copy of which you can download here.
Is Illumina (ILMN) Stock a Buy For 2021?
Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.
Is Illumina (ILMN) Stock a Buy For 2021?
Bonsai Partners recently released its Q4 2020 Investor Letter, a copy of which you can download here.
Polen Capital: Illumina (ILMN) Poised to Become ‘Even Larger and Stronger’ in $20B DNA Sequencing Market
Polen Capital Management, a value-driven, concentrated, long-term investment management firm, published its ‘Polen Focus Growth’ fourth-quarter 2020 Investor Letter – a ...
12 Best Large Biotech Stocks to Buy Now
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Want to Buy Illumina (ILMN) Stock? Here’s What You Need to Know
RiverPark Advisors, LLC recently published its Q3 2020 RiverPark Large Growth Fund commentary – a copy of which can be downloaded here.
Is Illumina (ILMN) a Smart Long-term Buy?
Baron Asset Fund recently published its third-quarter commentary – a copy of which can be downloaded here.
Was The Smart Money Right About Illumina, Inc. (ILMN)?
Although the masses and most of the financial media blame hedge funds for their exorbitant fee structure and disappointing performance, these investors have proved to have great...
Why Illumina (ILMN) Stock is a Compelling Investment Case
Bonsai Partners recently released its Q3 2020 Investor Letter, a copy of which you can download here.
